{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:04:13Z","timestamp":1777417453923,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.biopha.2018.02.042","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T07:56:00Z","timestamp":1519631760000},"page":"575-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["The protective effect of astaxanthin against cisplatin-induced nephrotoxicity in rats"],"prefix":"10.1016","volume":"100","author":[{"given":"Gorkem","family":"Akca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-8781","authenticated-orcid":false,"given":"Huseyin","family":"Eren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Tumkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolga","family":"Mercantepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa Ozan","family":"Horsanali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezgi","family":"Deveci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyup","family":"Dil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.02.042_bib0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2015.10.010","article-title":"Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model","volume":"77","author":"Elsherbiny","year":"2016","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.biopha.2018.02.042_bib0010","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0959-8049(98)00224-X","article-title":"Clinical development of platinum complexes in cancer therapy: an historical perspective and an update","volume":"34","author":"Lebwohl","year":"1998","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2018.02.042_bib0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00002820-199408000-00001","article-title":"Cisplatin: a clinical review part II-nursing assessment and management of side effects of cisplatin","volume":"17","author":"Cooley","year":"1994","journal-title":"Cancer Nurs."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.042_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.biopha.2018.02.042_bib0025","first-page":"445","article-title":"Coupling of energy to transport in proximal and distal nephron","volume":"3","author":"Gullans","year":"1992","journal-title":"Kidney: Physiol. Pathophysiol."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/PL00006741","article-title":"Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines","volume":"45","author":"Kr\u00f6ning","year":"2000","journal-title":"Cancer Chemother. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASN.0000042803.28024.92","article-title":"Metabolism of cisplatin to a nephrotoxin in proximal tubule cells","volume":"14","author":"Townsend","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.042_bib0040","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1006\/bbrc.1994.2306","article-title":"Cisplatin generates superoxide anion by interaction with DNA in a cell-free system","volume":"203","author":"Masuda","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2018.02.042_bib0045","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.V12122683","article-title":"Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide","volume":"12","author":"Davis","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1191\/0960327104ht413oa","article-title":"The effects of desferrioxamine on cisplatininduced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys","volume":"23","author":"Kadikoylu","year":"2004","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2210-4-20","article-title":"Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats","volume":"4","author":"Chirino","year":"2004","journal-title":"BMC Pharmacol."},{"issue":"18","key":"10.1016\/j.biopha.2018.02.042_bib0060","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.lfs.2004.11.005","article-title":"Naringenin attenuates cisplatin nephrotoxicity in rats","volume":"76","author":"Badary","year":"2005","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0065","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/0886022X.2015.1103585","article-title":"Total antioxidant and oxidant status of plasma and renal tissue of cisplatin-induced nephrotoxic rats: protection by floral extracts of Calendula officinalis Linn","volume":"38","author":"Verma","year":"2016","journal-title":"Ren. Fail."},{"issue":"6","key":"10.1016\/j.biopha.2018.02.042_bib0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00280-006-0231-8","article-title":"Protection against cisplatin-induced nephrotoxicity by Spirulina in rats","volume":"58","author":"Mohan","year":"2006","journal-title":"Cancer Chemother. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.042_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tox.2003.10.012","article-title":"Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats","volume":"195","author":"Naz\u0131ro\u01e7lu","year":"2004","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.biopha.2018.02.042_bib0080","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.3390\/ijms14036106","article-title":"Comparative analysis of serum (anti) oxidative status par\u0430meters in healthy persons","volume":"14","author":"Jansen","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12917-016-0792-7","article-title":"Spectrophotometric assays for total antioxidant capacity (TAC) in dog serum: an update","volume":"12","author":"Rubio","year":"2016","journal-title":"BMC Vet. Res."},{"issue":"9","key":"10.1016\/j.biopha.2018.02.042_bib0090","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/10715760500210145","article-title":"Total antioxidant capacity assay of human serum using copper (II)-neocuproine as chromogenic oxidant: the CUPRAC method","volume":"39","author":"Apak","year":"2005","journal-title":"Free Radic. Res."},{"issue":"4","key":"10.1016\/j.biopha.2018.02.042_bib0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","article-title":"A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation","volume":"37","author":"Erel","year":"2004","journal-title":"Clin. Biochem."},{"issue":"12","key":"10.1016\/j.biopha.2018.02.042_bib0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0924-2244(97)01092-3","article-title":"Food carotenoids and cancer prevention: an overview of current research","volume":"8","author":"Astorg","year":"1997","journal-title":"Trends Food Sci. Technol."},{"issue":"12","key":"10.1016\/j.biopha.2018.02.042_bib0105","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/ptr.3494","article-title":"Effects of astaxanthin on oxidative stress in overweight and obese adults","volume":"25","author":"Choi","year":"2011","journal-title":"Phytother. Res."},{"issue":"7","key":"10.1016\/j.biopha.2018.02.042_bib0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/A:1022877703008","article-title":"Screening and characterization of astaxanthin-hyperproducing mutants of Haematococcus pluvialis","volume":"25","author":"Chen","year":"2003","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.biopha.2018.02.042_bib0115","unstructured":"M. Anderson, Method of inhibiting 5\u03b1-reductase with astaxanthin. 2001, Google Patents."},{"issue":"5","key":"10.1016\/j.biopha.2018.02.042_bib0120","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0167-7799(03)00078-7","article-title":"Haematococcus astaxanthin: applications for human health and nutrition","volume":"21","author":"Guerin","year":"2003","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0125","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.bbrc.2017.11.047","article-title":"SENP1 attenuates the liver fibrosis through down-regulating the expression of SMAD2","volume":"495","author":"Wu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2018.02.042_bib0130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/0748233711434959","article-title":"Beneficial effect of astaxanthin on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced liver injury in rats","volume":"29","author":"Turkez","year":"2013","journal-title":"Toxicol. Ind. Health"},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.fct.2004.08.018","article-title":"Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced nephrotoxicity in mice","volume":"43","author":"Kim","year":"2005","journal-title":"Food Chem. Toxicol."},{"issue":"11","key":"10.1016\/j.biopha.2018.02.042_bib0140","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1080\/14767058.2016.1214124","article-title":"Lasting hepatotoxic effects of prenatal mobile phone exposure","volume":"30","author":"Yilmaz","year":"2017","journal-title":"J. Maternal-Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.042_bib0145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clinbiochem.2003.10.014","article-title":"A novel automated method to measure total antioxidant response against potent free radical reactions","volume":"37","author":"Erel","year":"2004","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.042_bib0150","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jfda.2016.07.002","article-title":"Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury","volume":"25","author":"Geyikoglu","year":"2017","journal-title":"J. Food Drug Anal."},{"issue":"7","key":"10.1016\/j.biopha.2018.02.042_bib0155","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/0886022X.2016.1184958","article-title":"Protective effects of estrogen and bortezomib in kidney tissue of post-menopausal rats: an ultrastructural study","volume":"38","author":"Mercantepe","year":"2016","journal-title":"Ren. Fail."},{"issue":"6","key":"10.1016\/j.biopha.2018.02.042_bib0160","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/cbf.3277","article-title":"Effects of propolis, caffeic acid phenethyl ester, and pollen on renal injury in hypertensive rat: an experimental and theoretical approach","volume":"35","author":"Salmas","year":"2017","journal-title":"Cell Biochem. Funct."},{"issue":"4","key":"10.1016\/j.biopha.2018.02.042_bib0165","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C","article-title":"Improvement of cis\u2010dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model","volume":"39","author":"Cvitkovic","year":"1977","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2018.02.042_bib0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002820-199406000-00001","article-title":"Cisplatin: a clinical review part I-current uses of cisplatin and administration guidelines","volume":"17","author":"Cooley","year":"1994","journal-title":"Cancer Nurs."},{"issue":"12","key":"10.1016\/j.biopha.2018.02.042_bib0175","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1177\/106002809302701219","article-title":"Newer insights into cisplatin nephrotoxicity","volume":"27","author":"Hartshorn","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.biopha.2018.02.042_bib0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biopha.2016.11.110","article-title":"Protective effect of Nigella sativa oil on cisplatin induced nephrotoxicity and oxidative damage in rat kidney","volume":"85","author":"Farooqui","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.biopha.2018.02.042_bib0185","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/ndt\/12.12.2478","article-title":"Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application","volume":"12","author":"Kuhlmann","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"issue":"9","key":"10.1016\/j.biopha.2018.02.042_bib0190","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.biopha.2018.02.042_bib0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2018.02.042_bib0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.taap.2017.04.013","article-title":"Targeting Oct2 and P53: formononetin prevents cisplatin-induced acute kidney injury","volume":"326","author":"Huang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.042_bib0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5049\/EBP.2014.12.2.55","article-title":"Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies","volume":"12","author":"Oh","year":"2014","journal-title":"Electrolytes Blood Press."},{"issue":"9","key":"10.1016\/j.biopha.2018.02.042_bib0210","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/08860220802353900","article-title":"Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats","volume":"30","author":"Gandhi","year":"2008","journal-title":"Ren. Fail."},{"issue":"3","key":"10.1016\/j.biopha.2018.02.042_bib0215","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/0886022X.2015.1006087","article-title":"The usefulness of carvedilol and nebivolol in preventing contrast nephropathy in rats","volume":"37","author":"Akg\u00fcll\u00fc","year":"2015","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.biopha.2018.02.042_bib0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am. J. Med. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2018.02.042_bib0225","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/ijms18071407","article-title":"Nephroprotective effects of saponins from leaves of Panax quinquefolius against cisplatin-induced acute kidney injury","volume":"18","author":"Ma","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2018.02.042_bib0230","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.fct.2006.01.013","article-title":"Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research","volume":"44","author":"Ali","year":"2006","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1248\/bpb.28.47","article-title":"Antihypertensive and neuroprotective effects of astaxanthin in experimental animals","volume":"28","author":"Hussein","year":"2005","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.biopha.2018.02.042_bib0240","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1271\/bbb.60521","article-title":"Effects of astaxanthin in obese mice fed a high-fat diet","volume":"71","author":"Ikeuchi","year":"2007","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/biof.5520200105","article-title":"Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db\/db mice","volume":"20","author":"Naito","year":"2004","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.biopha.2018.02.042_bib0250","doi-asserted-by":"crossref","first-page":"e0146438","DOI":"10.1371\/journal.pone.0146438","article-title":"Astaxanthin inhibits expression of retinal oxidative stress and inflammatory mediators in streptozotocin-induced diabetic rats","volume":"11","author":"Yeh","year":"2016","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.biopha.2018.02.042_bib0255","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/1389201017666160922110740","article-title":"Astaxanthin; a promising protector against gentamicin-induced nephrotoxicity in rats","volume":"17","author":"Mosaad","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2018.02.042_bib0260","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/j.1523-1755.2004.66010.x","article-title":"Caspase-1\u2013deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis","volume":"66","author":"Faubel","year":"2004","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.biopha.2018.02.042_bib0265","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3390\/md13042105","article-title":"Astaxanthin attenuates early acute kidney injury following severe burns in rats by ameliorating oxidative stress and mitochondrial-related apoptosis","volume":"13","author":"Guo","year":"2015","journal-title":"Mar. Drugs"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T18:04:21Z","timestamp":1761242661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":53,"alternative-id":["S0753332218300088"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.02.042","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protective effect of astaxanthin against cisplatin-induced nephrotoxicity in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}